A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Clinical trial NCT04694560 · WITHDRAWN
Trial details
- NCT number
- NCT04694560
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-22
- Primary completion
- 2023-03-06
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.